IP Library Granted Patent US 12,303,692
Granted Patent B2
US 12,303,692 · App. 17/501,732 · Granted May 20, 2025

Devices and methods for sensing physiological signals during stimulation therapy

Inventors: Scott Stanslaski (Shoreview, MN); Robert Devine (New Brighton, MN); Timothy Denison (Minneapolis, MN); Vincent Roczniak (Maple Grove, MN); Todd Smith (Shoreview, MN); Thomas Adamski (Andover, MN)
Assignee: Medtronic, Inc.
A61N1/36139A61N1/0529A61N1/0534A61N1/0553A61N1/3615A61N1/36178A61N1/378
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,303,692
App. No.
17/501,732
Granted
May 20, 2025
Kind
B2
Abstract

Devices and methods provide for the sensing of physiological signals by providing a stimulation waveform that includes a stimulation pulse followed by an active recharge pulse to clear the charge in capacitors within the stimulation path. The active recharge pulse is followed by a period of passive recharge and then a period of no recharge. Non-neurological sources of artifacts within the sensed physiological signal may be handled by providing a brief period of passive recharge followed by a lengthy period of no recharge, which is made possible by the use of the active recharge pulse prior to the passive recharge. The period of no recharge removes any low impedance path to ground from the stimulation electrodes, which allows an amplifier of the sensing circuit to provide common mode rejection of non-neurological signals, such as cardiac signals, present at the sensing electrodes.

Claims (31)

1. A method of setting an active recharge ratio of an implantable stimulation device, comprising:

repeatedly providing from the implantable medical device stimulation waveforms that include a stimulation pulse followed by an active recharge pulse where each stimulation waveform utilizes a different active recharge ratio from other stimulation waveforms being provided where the active recharge ratio is based on an active recharge pulse amplitude relative to a baseline active recharge pulse amplitude;

sensing at the implantable medical device a sensed signal at a time between each of the stimulation waveforms being provided;

determining a peak-to-peak amplitude for each sensed signal;

selecting the active recharge ratio of the stimulation waveform that immediately preceded the sensed signal with the smallest peak-to-peak amplitude; and

using the selected active recharge ratio in subsequent stimulation waveforms provided by the implantable medical device.

2. The method of claim 1 , wherein the baseline active recharge pulse amplitude corresponds to an amplitude of the stimulation pulse.

3. The method of claim 1 , wherein the active recharge ratios comprise 0.8, 0.9, 1, 1.1, and 1.2.

4. The method of claim 1 , further comprising after using the selected active recharge ratio in subsequent stimulation waveforms, receiving a trigger at the implantable medical device and again repeatedly providing the stimulation waveforms utilizing different active recharge ratios, again sensing at the implantable medical device the sensed signal between the stimulation waveforms, again determining the peak-to-peak amplitude for each sensed signal, again selecting the active recharge ratio that immediately preceded the sensed signal with the smallest peak-to-peak amplitude, and again using the selected active recharge ratio in subsequent stimulation waveforms provided by the implantable medical device.

5. The method of claim 4 , wherein the trigger is new stimulation waveform programming.

6. The method of claim 4 , wherein the trigger is reaching a set amount of time.

7. The method of claim 1 , wherein sensing a sensed signal comprises producing a differential signal while applying common mode rejection.

8. The method of claim 1 , wherein the stimulation waveform also includes a period of passive recharge following the active recharge pulse.

9. The method of claim 8 , wherein the stimulation waveform also includes a period of no recharge following the passive recharge.

10. An implantable medical device, comprising:

a stimulation engine that can produce a stimulation waveform including a stimulation pulse and an active recharge pulse;

a sensing circuit that can obtain a sensed signal;

a controller that is coupled to the stimulation engine and the sensing circuit, the controller being configured to:

cause the stimulation engine to repeatedly provide stimulation waveforms that include a stimulation pulse followed by an active recharge pulse where each stimulation waveform utilizes a different active recharge ratio from other stimulation waveforms being provided where the active recharge ratio is based on an active recharge pulse amplitude relative to a baseline active recharge pulse amplitude;

cause the sensing circuit to sense a sensed signal at a time between each of the stimulation waveforms being provided;

determine a peak-to-peak amplitude for each sensed signal;

select the active recharge ratio of the stimulation waveform that immediately preceded the sensed signal with the smallest peak-to-peak amplitude; and

cause the stimulation engine to use the selected active recharge ratio in subsequent stimulation waveforms.

11. The implantable medical device of claim 10 , wherein the baseline active recharge pulse amplitude corresponds to an amplitude of the stimulation pulse.

12. The implantable medical device of claim 10 , wherein the active recharge ratios comprise 0.8, 0.9, 1, 1.1, and 1.2.

13. The implantable medical device of claim 10 , wherein the controller is further configured to, after using the selected active recharge ratio in subsequent stimulation waveforms, receive a trigger and again cause the stimulation engine to repeatedly provide the stimulation waveforms utilizing different active recharge ratios, again cause the sensing circuit to sense the sensed signal between the stimulation waveforms, again determine the peak-to-peak amplitude for each sensed signal, again select the active recharge ratio that immediately preceded the sensed signal with the smallest peak-to-peak amplitude, and again cause the stimulation engine to use the selected active recharge ratio in subsequent stimulation waveforms.

14. The implantable medical device of claim 13 , wherein the trigger is new stimulation waveform programming.

15. The implantable medical device of claim 13 , wherein the trigger is reaching a set amount of time.

16. The implantable medical device of claim 10 , wherein the sensing circuit senses a sensed signal by producing a differential signal while applying common mode rejection.

17. The implantable medical device of claim 10 , wherein the stimulation waveform also includes a period of passive recharge following the active recharge pulse.

18. The implantable medical device of claim 17 , wherein the stimulation waveform also includes a period of no recharge following the passive recharge.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2021
From: ADAMSKI, THOMAS; DEVINE, ROBERT; DENISON, TIMOTHY; ROCZNIAK, VINCENT; SMITH, TODD; STANSLASKI, SCOTT
To: MEDTRONIC, INC.
Reel/Frame 057802/0958 →
Continuity (3)
Continuation 16590661 · Oct 2, 2019
Division 15444997 · Feb 28, 2017
Related Publication 20220032065A1 · Feb 3, 2022
References Cited (30)
US 7751888B1 · Schecter · 2010 [cited by applicant]
US 9238141B2 · Hocken et al. · 2016 [cited by applicant]
US 10471259B2 · Stanslaski et al. · 2019 [cited by applicant]
US 11160983B2 · Stanslaski et al. · 2021 [cited by applicant]
US 20030204223A1 · Leinders et al. · 2003 [cited by applicant]
US 20060064149A1 · Belacazar et al. · 2006 [cited by applicant]
US 20060224199A1 · Zeijlemaker · 2006 [cited by examiner]
US 20100114209A1 · Krause et al. · 2010 [cited by applicant]
US 20110295336A1 · Sharma et al. · 2011 [cited by applicant]
US 20140163638A1 · Marnfeldt et al. · 2014 [cited by applicant]
US 20140277268A1 · Lee · 2014 [cited by applicant]
US 20150051670A1 · Hocken et al. · 2015 [cited by applicant]
US 20150164354A1 · Parker et al. · 2015 [cited by applicant]
US 20150223710A1 · Cong et al. · 2015 [cited by applicant]
US 20150273217A1 · Legay et al. · 2015 [cited by applicant]
CN 105873635 · 2016 [cited by applicant]
CN 106255526 · 2016 [cited by applicant]
JP 2014522261 · 2014 [cited by applicant]
JP 2016503333 · 2016 [cited by applicant]
Chinese Application No. 201880014255.X Notice of Office Action, Feb. 22, 2023. [cited by applicant]
International Preliminary Report on Patentability from International Application No. PCT/US2018/012758 dated Sep. 3, 2019, 7 pp. [cited by applicant]
Notice of Intent to Grant and Text Intended to Grant from counterpart European Application No. 18701867.6 dated Feb. 12, 2021, 70 pp. [cited by applicant]
Notice of Intent to Grant and Text Intended to Grant from counterpart European Application No. 18701867.6 dated Oct. 20, 2021, 144 pp. [cited by applicant]
Notice of Intent to Grant, and translation thereof, from counterpart Japanese Application No. 2019-544646 dated Jul. 26, 2022, 5 pp. [cited by applicant]
Prosecution History from U.S. Appl. No. 15/444,997, now issued U.S. Pat. No. 10,471,259, dated Oct. 3, 2018 through Jul. 2, 2019, 31 pp. [cited by applicant]
Prosecution History from U.S. Appl. No. 16/590,661, now issued U.S. Pat. No. 11,160,983, dated Mar. 31, 2021 through Aug. 18, 2021, 24 pp. [cited by applicant]
Response to Communication Pursuant to Rules 161(1) and 162 EPC dated Oct. 7, 2019, from counterpart European Application No. 18701867.6, filed Mar. 12, 2020, 14 pp. [cited by applicant]
Japanese Patent Application No. 2019-544646, Office Action, Jun. 15, 2021. [cited by applicant]
PCT Application No. PCT/US2018/012758 International Search Report and Written Opinion, May 8, 2018. [cited by applicant]
Japanese Patent Application No. 2019-544646, Office Action, Jan. 24, 2022. [cited by applicant]
Cited By (1)
US 12,636,493